Zhuhai Rundu Pharmaceutical Co Ltd Class A (002923) — Strategic Asset Allocation Index
Zhuhai Rundu Pharmaceutical Co Ltd Class A (002923) has a Strategic Asset Allocation Index of 100.9% as of September 2023. Strategic assets (PP&E of CN¥1.19 Billion plus long-term investments of CN¥-) total CN¥1.19 Billion, measured against net assets of CN¥1.18 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Zhuhai Rundu Pharmaceutical Co Ltd Class (002923) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Zhuhai Rundu Pharmaceutical Co Ltd Class A Strategic Asset Allocation Index (2016–2022)
This chart shows how Zhuhai Rundu Pharmaceutical Co Ltd Class A's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of September 2023, the index stands at 100.9%, representing strategic assets of CN¥1.19 Billion against net assets of CN¥1.18 Billion CNY. For live market cap and overall valuation, see Zhuhai Rundu Pharmaceutical Co Ltd Class market capitalisation.
Annual Strategic Asset Allocation Index for Zhuhai Rundu Pharmaceutical Co Ltd Class A (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Zhuhai Rundu Pharmaceutical Co Ltd Class A from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 002923 total equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 102.3% | CN¥1.22 Billion | CN¥1.22 Billion | CN¥- | CN¥1.20 Billion | ▲ +14.9 pp |
| 2021 | 87.4% | CN¥972.57 Million | CN¥972.57 Million | CN¥- | CN¥1.11 Billion | ▲ +31.4 pp |
| 2020 | 56.1% | CN¥581.99 Million | CN¥581.99 Million | CN¥- | CN¥1.04 Billion | ▲ +9.2 pp |
| 2019 | 46.8% | CN¥440.44 Million | CN¥440.44 Million | CN¥- | CN¥940.29 Million | ▲ +11.3 pp |
| 2018 | 35.5% | CN¥309.38 Million | CN¥309.38 Million | CN¥- | CN¥871.29 Million | ▼ -15.3 pp |
| 2017 | 50.8% | CN¥248.42 Million | CN¥248.42 Million | CN¥- | CN¥488.84 Million | ▼ -12.6 pp |
| 2016 | 63.5% | CN¥252.67 Million | CN¥252.67 Million | CN¥- | CN¥398.19 Million | — |